, "operator recorded use" (group 1) was from phone company records and "self-reported use" (group 2) had the identical numbers of case and control subjects. Yet when case and control subjects are compared by use categories, the numbers differ.
The article states that operator data were available for 35% and 34% of the case and control subjects, respectively, whereas data reported from operators in table 4 include 56.7% of both subject groups.
Twelve of the 13 laterality results indicated higher risks of contralateral than ipsilateral tumors. However, this article's definitions of ipsilateral and contralateral use differed from dictionary definitions and from those used in all previous cell phone studies ( Table 1) .
The authors reported 423 eligible case and 909 eligible control subjects, with participation by 352 (83.2%) case and 646 (71.0%) control subjects, resulting in exclusion of 71 case and 263 control subjects. When the reasons for exclusion are summed, there were 121 case subjects (50 additional) and 280 control subjects (17 additional). This would result in case participation of 60% and control participation of 69%, which in turn would likely increase various biases.
Other data discrepancies of Aydin et al. (1) are excluding the most common childhood brain tumor, pilocytic astrocytoma (histology code, 9421), whereas ependymoma, glioma, malignant no specific type, and medulloblastoma (primitive neuroectodermal tumor) were included. In the United States, the incidence of each of these rare tumors decreases with increasing age (6) . Commenting on the implications of these declining rates with age, Dr Michael Kundi published his finding [16 months before Aydin et al. (1) ] that, "brain tumours with no or decreasing incidence trends for increasing age must be omitted from analysis, at least for short exposure durations" (7) .
Finally, the Funding and Notes section reported that several cell phone companies provided funding for this study, but there were no declarations regarding individual authors' financial support or conflicts of interest.
These numerous discrepancies suggest a poor peer-review process and/or a rush to publish. Overall, the findings of Aydin et al.
(1) are supportive of a positive relationship between cell phone use in children and increased risk for brain tumors with shorter latency than those that have generally been found for adults. In that regard, it is noteworthy that Cardis et al. (3) recently reported that heaviest cell phone users had a statistically significantly (P = .01) "increasing trend in gliomas with increasing radiofrequency dose after seven years."
Further study is clearly merited on this important issue.
